JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M209992200 on October 9, 2002

J. Biol. Chem., Vol. 278, Issue 1, 491-497, January 3, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/1/491    most recent
M209992200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Altroff, H.
Right arrow Articles by Mardon, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Altroff, H.
Right arrow Articles by Mardon, H. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Synergistic Activity of the Ninth and Tenth FIII Domains of Human Fibronectin Depends upon Structural Stability*

Harri Altroff, Laurence Choulier, and Helen J. MardonDagger

From the Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Women's Centre, John Radcliffe Hospital, Headington, Oxford OX3 9DU, United Kingdom

The ninth and tenth FIII domains (FIII9-10) of human fibronectin act in synergy to promote cell adhesion via the interaction with integrin receptors. Here we describe the functional and structural properties of a set of recombinant FIII9-10 mutants containing various alanine substitutions within the key synergistic site, DRVPHSRN in FIII9, either alone or in combination with another substitution (Leu1408 to Pro), on the opposite face of FIII9, that increases stability and the functional capacity of FIII9-10. We show that the introduction of mutations into the synergistic sequence of FIII9-10 has a negative effect on the adhesion of baby hamster kidney fibroblasts and results in reduced ability of these ligands to recognize integrin alpha 5beta 1. Conformational stability of the FIII9 domain in the synergy site mutants is likewise reduced in comparison with native FIII9. The Leu1408 to Pro substitution in mutant FIII9-10 proteins carrying substitutions in the synergy site results in a substantial recovery of the adhesive activity of the mutants and affinity to alpha 5beta 1. In keeping with the enhancement of functional activity, the Leu1408 to Pro substitution in the FIII9-10 synergy site mutants also causes a significant increase in conformational stability of FIII9. These observations imply a strong positive correlation between the biological activity and conformational stability of the assessed FIII9-10 mutants and suggest that a Leu1408 to Pro substitution restores the biological activity of the mutants via their ability to restore their conformational stability. We conclude that domain stability may be a major determinant of the synergistic potential of FIII9. Our data underscore the value of using more than one approach in such structure-function studies and the requirement for validating the global structural integrity of protein ligands in which sequences that disrupt function have been perturbed.


* This work was supported by the Wellcome Trust and the Medical Research Council.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 44-1865-222936; E-mail: hmardon@molbiol.ox.ac.uk.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Jovanovic, J. Takagi, L. Choulier, N. G. A. Abrescia, D. I. Stuart, P. A. van der Merwe, H. J. Mardon, and P. A. Handford
{alpha}Vbeta6 Is a Novel Receptor for Human Fibrillin-1: COMPARATIVE STUDIES OF MOLECULAR DETERMINANTS UNDERLYING INTEGRIN-RGD AFFINITY AND SPECIFICITY
J. Biol. Chem., March 2, 2007; 282(9): 6743 - 6751.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Sumathipala, C. Xu, J. Seago, A. P. Mould, M. J. Humphries, S. E. Craig, Y. Patel, E. S. Wijelath, M. Sobel, and S. Rahman
The "Linker" Region (Amino Acids 38-47) of the Disintegrin Elegantin Is a Novel Inhibitory Domain of Integrin {alpha}5beta1-Dependent Cell Adhesion on Fibronectin: EVIDENCE FOR THE NEGATIVE REGULATION OF FIBRONECTIN SYNERGY SITE BIOLOGICAL ACTIVITY
J. Biol. Chem., December 8, 2006; 281(49): 37686 - 37696.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Altroff, R. Schlinkert, C. F. van der Walle, A. Bernini, I. D. Campbell, J. M. Werner, and H. J. Mardon
Interdomain Tilt Angle Determines Integrin-dependent Function of the Ninth and Tenth FIII Domains of Human Fibronectin
J. Biol. Chem., December 31, 2004; 279(53): 55995 - 56003.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P. Mould, E. J. H. Symonds, P. A. Buckley, J. G. Grossmann, P. A. McEwan, S. J. Barton, J. A. Askari, S. E. Craig, J. Bella, and M. J. Humphries
Structure of an Integrin-Ligand Complex Deduced from Solution X-ray Scattering and Site-directed Mutagenesis
J. Biol. Chem., October 10, 2003; 278(41): 39993 - 39999.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.